Drug Shortage Report for TARO-TADALAFIL
Report ID | 31239 |
Drug Identification Number | 02452073 |
Brand name | RAN-TADALAFIL |
Common or Proper name | RAN-TADALAFIL |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-11-30 |
Actual start date | 2017-11-30 |
Estimated end date | Unknown |
Actual end date | 2018-07-09 |
Shortage status | Resolved |
Updated date | 2019-02-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-11-30 | English | Compare |
v2 | 2017-11-30 | French | Compare |
v3 | 2017-12-01 | English | Compare |
v4 | 2017-12-15 | English | Compare |
v5 | 2017-12-15 | French | Compare |
v6 | 2018-01-18 | English | Compare |
v7 | 2018-01-18 | French | Compare |
v8 | 2018-02-05 | English | Compare |
v9 | 2018-02-05 | French | Compare |
v10 | 2018-03-23 | English | Compare |
v11 | 2018-03-23 | French | Compare |
v12 | 2019-02-01 | English | Compare |
v13 | 2019-02-01 | French | Compare |
Showing 1 to 13 of 13